Meeting on the Med 2021 | Accelerating commercialization in advanced therapies

Pascal Touchon, President & CEO, Atara Biotherapeutics, San Francisco, CA, describes a panel discussion that took place at the Cell & Gene Meeting on the Mediterranean 2021 virtual conference, in which leading experts discussed how the field can accelerate the commercialisation of cell and gene therapies. He highlights challenges associated with the regulation of these innovative therapies and proposes that regulatory agencies need to work closely with the industry in order to establish the critical criteria required to demonstrate the efficacy and safety of cell and gene therapies. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.